| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 37 | US FAERS | |
| 2 | Zoledronic Acid | FAERS: 18 | US FAERS | |
| 3 | Clozapine | FAERS: 4 | US FAERS | |
| 4 | Vemurafenib | FAERS: 4 | US FAERS | |
| 5 | pirfenidone | FAERS: 3 | US FAERS | |
| 6 | teriflunomide | FAERS: 3 | US FAERS | |
| 7 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 8 | Atomoxetine Hydrochloride | FAERS: 2 | US FAERS | |
| 9 | Paroxetine | FAERS: 2 | US FAERS | |
| 10 | Rosiglitazone | FAERS: 2 | US FAERS | |
| 11 | carbidopa, levodopa drug combination | FAERS: 2 | US FAERS | |
| 12 | Atorvastatin | FAERS: 1 | US FAERS | |
| 13 | Cyclosporine | FAERS: 1 | US FAERS | |
| 14 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 15 | Everolimus | FAERS: 1 | US FAERS | |
| 16 | Isotretinoin | FAERS: 1 | US FAERS | |
| 17 | Lapatinib | FAERS: 1 | US FAERS | |
| 18 | Octreotide | FAERS: 1 | US FAERS | |
| 19 | Rifaximin | FAERS: 1 | US FAERS | |
| 20 | Rivastigmine | FAERS: 1 | US FAERS | |
| 21 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 22 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 23 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 24 | adefovir dipivoxil | FAERS: 1 | US FAERS | |
| 25 | niraparib | FAERS: 1 | US FAERS | |
| 26 | telotristat ethyl | FAERS: 1 | US FAERS | |
| 27 | tofacitinib | FAERS: 1 | US FAERS | |
| 28 | Decitabine | SIDER | ||
| 29 | Olanzapine | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.